Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;15(4):406-12.
doi: 10.1093/neuonc/nos309. Epub 2013 Jan 14.

Treatment, prognostic factors, and outcomes in spinal cord astrocytomas

Affiliations

Treatment, prognostic factors, and outcomes in spinal cord astrocytomas

Mohamad H Fakhreddine et al. Neuro Oncol. 2013 Apr.

Abstract

Background: Spinal astrocytomas are rare intramedullary CNS tumors for which there is limited consensus on treatment; the importance of the extent of resection (EOR), postoperative radiotherapy, and chemotherapy remains poorly understood. We report on outcomes associated with surgery, postoperative radiotherapy, and chemotherapy in a series of patients treated at M. D. Anderson Cancer Center (MDACC) with the aim of elucidating the role of these treatments in spinal astrocytomas.

Methods: We retrospectively reviewed charts from a series of 83 patients with histologically confirmed spinal astrocytoma treated at MDACC during 1990-2011. Data collected included patient demographic characteristics, prognostic indicators, and treatment modality at diagnosis. We analyzed overall survival (OS) and progression-free survival (PFS) for pilocytic (World Health Organization [WHO] grade I) and infiltrative (WHO grades II, III, and IV) astrocytomas, separately. Multivariate analysis was performed for the infiltrative patients but not the pilocytic patients because of a limited number of cases.

Results: Higher WHO grade among all patients was associated with worse OS (P < .0001) and PFS (P = .0003). Among patients with infiltrative tumors, neither EOR nor radiotherapy was associated with a difference in outcomes in multivariate analysis; however, among patients with infiltrative astrocytomas, chemotherapy was significantly associated with improved PFS (hazard ratio = .22, P = .0075) but not OS (hazard ratio = .89, P = .83) in multivariate analysis.

Conclusion: WHO grade was the strongest prognostic indicator in patients with spinal cord astrocytomas. Our results also show that chemotherapy improved PFS in infiltrative astrocytomas in multivariate analysis, but neither EOR nor radiation therapy influenced outcomes in this group.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Kaplan-Meier plot of overall survival and progression-free survival among patients with pilocytic and infiltrative tumors. aLog-rank test.

References

    1. Raco A, Piccirilli M, Landi A, et al. High-grade intramedullary astrocytomas: 30 years’ experience at the Neurosurgery Department of the University of Rome “Sapienza”. J Neurosurg Spine. 2010;12(2):144–153. - PubMed
    1. Minehan KJ, Brown PD, Scheithauer BW, et al. Prognosis and treatment of spinal cord astrocytoma. Int J Radiat Oncol Biol Phys. 2009;73(3):727–733. - PubMed
    1. Minehan KJ, Shaw EG, Scheithauer BW, et al. Spinal cord astrocytoma: pathological and treatment considerations. J Neurosurg. 1995;83(4):590–595. - PubMed
    1. Constantini S, Miller DC, Allen JC, et al. Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg. 2000;93(2 Suppl):83–193. - PubMed
    1. Nakamura M, Chiba K, Ishii K, et al. Surgical outcomes of spinal cord astrocytomas. Spinal Cord. 2006;44(12):740–745. - PubMed

MeSH terms